Pathogenic Roles of TSH-Receptor Antibodies in Graves’ Disease

  • Shigenobu Nagataki

Abstract

Since the discovery of long acting thyroid stimulator, the significance of circulating abnormal thyroid stimulators or TSH-receptor antibodies in untreated patients with Graves’ disease has been investigated extensively by numerous investigators. However, the pathogenic roles of TSH-receptor antibodies for thyrotoxicosis of Graves’ disease are still not completely elucidated.

Keywords

Interferon Thyrotoxicosis Triiodothyronine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    N. Kuzuya, S.C. Chiu, H. Ikeda, H. Ikeda, H. Uchimura, K. Ito, and S. Nagataki, Correlation between Thyroid Stimulators and 3, 5, 3’- Triiodothyronine Suppressibility in Patients during Treatment for Hyperthyroidism with Thionamide Drugs: Comparison of Assays by Thyroid-Stimulating and Thyrotropin-Displacing Activities, J Clin Endocrinol Metab. 48: 706 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    N. Yokoyama, M. Izumi, and S. Nagataki, Heterogeneity of Graves 1 IgG: Comparison of TSH Receptor Antibodies in Serum and in Culture Supernatants of Lymphocytes Transformed by EB Virus Infection, J Clin Endocrinol Metab. (in press).Google Scholar
  3. 3.
    S. Nagataki, Pathogenic Factors of Graves 1 disease, in: “Current problems in Thyroid reseach,” N. Ui, K. Torizuka, S. Nagataki, and K. Miyai, ed., Excerpta Medica, Amsterdam-Oxford-Princeton (1982).Google Scholar
  4. 4.
    N. Hamada, T. Okabe, K. Kubota, S.C. Chiu, H. Uchimura, T. Mimura, K. Ito, and S. Nagataki, Chronic Effect of TSH on Human Thyroid Tissue in Organ Culture, Proc Soc Exp Biol Med. 172: 153 (1983).PubMedGoogle Scholar
  5. 5.
    S. Yamashita, M. Izumi, and S. Nagataki, Specific stimulatory effects of Graves’ IgG on the release of triiodothyronine from the patients’ own thyroids, Acta Endocrinol. 112: 204 (1986).PubMedGoogle Scholar
  6. 6.
    M. Londei, G.F. Bottazzo, and M. Feldman, Human T-Cell Clones from Autoimmune Thyroid Glands: Specific Recognition of Autologous Thyroid Cells, Science. 228: 85 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    T. Hanafusa, L. Chiovato, D. Doniach, R. Pujol-Borrell, R.C.G. Russell, G.F. Bottazzo, Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity, Lancet. 2: 1111 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    M. Matsunaga, K. Eguchi, T. Fukuda, A. Kurata, H. Tezuka, C. Shimomura, T. Otsubo, N. Ishikawa, K. Ito, and S. Nagataki, Class II Major Histocompatibility Complex Antigen Expression and Cellular Interaction in Thyroid Glands of Graves’ Disease, J Clin Endocrinol Metab. 62: 723 (1986).PubMedCrossRefGoogle Scholar
  9. 9.
    H. Tamai. H. Uno, Y. Hirota, S. Matsubayashi, K. Kuma, H. Matsumoto, L.F. Kumagai, T. Sasazuki, and S. Nagataki, Immunogenetics of Hashimoto’s and Graves’ Diseases, J Clin Endocrinol Metab. 60: 62 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Shigenobu Nagataki
    • 1
  1. 1.The First Department of Internal MedicineNagasaki University School of MedicineNagasaki 852Japan

Personalised recommendations